-
-
-
-
-
-
-
Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
-
-
-
-
-
-
-
ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update
-
-
-
-
-
-
-
Pre-Open Stock Movers 09/08: (KDMN) (GANX) (ADMA) Higher; (COTY) (PATH) (IMPL) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Stock Movers 02/07: (ASRT) (OCN) (PINS) Higher (ZGNX) (MYGN) (RESN) Lower (more...)
-
-
-
-
-
-
-
ADMA Biologics to Present at 2019 Cantor Global Healthcare Conference
-
-
-
-
-
-
-
ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM® and Nabi-HB®
-
-
-
-
-
-
-
FDA Approves Prior Approval Supplement for BIVIGAM®
-
1,177,581 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

